Seelos Therapeutics (SEEL) Short Interest Ratio & Short Volume → Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (From American Hartford Gold Group) (Ad) Free SEEL Stock Alerts $0.29 -0.01 (-3.34%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Seelos Therapeutics Short Interest DataCurrent Short Volume684,600 sharesPrevious Short Volume726,800 sharesChange Vs. Previous Month-5.81%Dollar Volume Sold Short$298,485.60Short Interest Ratio / Days to Cover1.6Last Record DateApril 15, 2024Outstanding Shares16,610,000 sharesFloat Size12,490,000 sharesShort Percent of Float5.48%Today's Trading Volume295,898 sharesAverage Trading Volume425,797 sharesToday's Volume Vs. Average69% Short Selling Seelos Therapeutics ? Sign up to receive the latest short interest report for Seelos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSEEL Short Interest Over TimeSEEL Days to Cover Over TimeSEEL Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Seelos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024684,600 shares $298,485.60 -5.8%5.5%1.6 $0.44 3/31/2024726,800 shares $429,538.80 -10.8%5.8%1.6 $0.59 3/15/2024815,000 shares $812,962.50 +178.2%6.5%1.9 $1.00 2/29/2024293,000 shares $377,970.00 -5.6%2.4%0.6 $1.29 2/15/2024310,500 shares $258,056.55 -24.1%2.6%0.4 $0.83 1/31/2024409,100 shares $417,282.00 -70.1%3.4%0.6 $1.02 Get the Latest News and Ratings for SEEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,370,000 shares $1.93 million +61.8%14.4%2.1 $1.41 12/31/2023846,900 shares $1.18 million -1.4%8.9%1.4 $1.39 12/15/2023859,300 shares $1.34 million +6.2%9.2%1.5 $1.56 11/30/2023808,800 shares $1.02 million -91.6%11.2%1.4 $1.26 11/15/20239,650,000 shares $34.88 million +16.0%N/A1.6 $3.62 10/31/20238,320,000 shares $1.55 million -0.8%N/A1.6 $0.19 10/15/20238,390,000 shares $1.54 million -18.0%N/A1.8 $0.18 9/30/202310,230,000 shares $1.88 million +66.3%N/A2.5 $0.18 9/15/20236,150,000 shares $5.67 million +2.0%N/A2 $0.92 8/31/20236,030,000 shares $6.57 million +10.4%N/A6.6 $1.09 8/15/20235,460,000 shares $6.39 million -2.0%N/A6.3 $1.17 7/31/20235,570,000 shares $8.52 million +5.3%N/A7.5 $1.53 7/15/20235,290,000 shares $6.98 million -4.3%N/A7.8 $1.32 6/30/20235,530,000 shares $6.61 million -3.0%N/A10 $1.20 6/15/20235,700,000 shares $5.99 million +4.0%N/A11.1 $1.05 5/31/20235,480,000 shares $5.10 million -5.7%N/A11.7 $0.93 5/15/20235,810,000 shares $5.28 million -11.0%N/A11.2 $0.91 4/30/20236,530,000 shares $4.51 million +3.8%N/A12.6 $0.69 4/15/20236,290,000 shares $4.91 million -6.1%N/A11.6 $0.78 3/31/20236,700,000 shares $4.63 million -1.0%N/A12 $0.69 3/15/20236,770,000 shares $4.23 million +7.5%N/A11.1 $0.63 2/28/20236,300,000 shares $4.98 million +5.7%N/A9.2 $0.79 2/15/20235,960,000 shares $4.41 million +4.4%N/A9 $0.74 1/31/20235,710,000 shares $4.64 million -0.4%N/A9.1 $0.81 1/15/20235,730,000 shares $5.21 million No ChangeN/A8.8 $0.91 12/30/20225,730,000 shares $3.89 million -3.2%N/A9 $0.68 12/15/20225,920,000 shares $6.45 million +1.7%N/A9.3 $1.09 11/30/20225,820,000 shares $4.76 million +4.7%N/A8.8 $0.82 11/15/20225,560,000 shares $5.00 million -3.1%N/A8 $0.90 10/31/20225,740,000 shares $4.99 million -10.0%N/A6 $0.87 10/15/20226,380,000 shares $5.79 million +0.2%N/A6.4 $0.91 9/30/20226,370,000 shares $6.56 million +1.8%N/A6.3 $1.03 9/15/20226,260,000 shares $8.01 million +11.0%N/A4.7 $1.28 8/31/20225,640,000 shares $6.37 million +5.8%N/A4.3 $1.13Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! SEEL Short Interest - Frequently Asked Questions What is Seelos Therapeutics' current short interest? Short interest is the volume of Seelos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 684,600 shares of SEEL short. 5.48% of Seelos Therapeutics' shares are currently sold short. Learn More on Seelos Therapeutics' current short interest. What is a good short interest ratio for Seelos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SEEL shares currently have a short interest ratio of 2.0. Learn More on Seelos Therapeutics's short interest ratio. What is a good short interest percentage for Seelos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.48% of Seelos Therapeutics' floating shares are currently sold short. Is Seelos Therapeutics' short interest increasing or decreasing? Seelos Therapeutics saw a decrease in short interest in April. As of April 15th, there was short interest totaling 684,600 shares, a decrease of 5.8% from the previous total of 726,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Seelos Therapeutics' float size? Seelos Therapeutics currently has issued a total of 16,610,000 shares. Some of Seelos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Seelos Therapeutics currently has a public float of 12,490,000 shares. How does Seelos Therapeutics' short interest compare to its competitors? 5.48% of Seelos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Seelos Therapeutics: Evoke Pharma, Inc. (0.54%), ZyVersa Therapeutics, Inc. (6.14%), Soligenix, Inc. (8.00%), TransCode Therapeutics, Inc. (0.28%), GT Biopharma, Inc. (0.27%), Atreca, Inc. (0.37%), Revelation Biosciences, Inc. (1.13%), Tharimmune, Inc. (0.90%), Longeveron Inc. (9.34%), Genprex, Inc. (2.69%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Seelos Therapeutics stock? Short selling SEEL is an investing strategy that aims to generate trading profit from Seelos Therapeutics as its price is falling. SEEL shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Seelos Therapeutics? A short squeeze for Seelos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SEEL, which in turn drives the price of the stock up even further. How often is Seelos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SEEL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ZVSA Short Interest NEXI Short Interest KZIA Short Interest PTPI Short Interest DRUG Short Interest SNPX Short Interest LIPO Short Interest GNPX Short Interest GTBP Short Interest FWBI Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SEEL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupUrgent Nvidia WarningAltimetry